These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 17461162)

  • 1. [Guideline for intravenous rt-PA therapy of patients with ischemic stroke].
    Takada T
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():286-91. PubMed ID: 17461162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis.
    Georgiadis AL; Memon MZ; Shah QA; Vazquez G; Suri MF; Lakshminarayan K; Qureshi AI
    J Neuroimaging; 2011 Apr; 21(2):113-20. PubMed ID: 19909396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for intravenous thrombolytic therapy in acute ischemic stroke with special reference to those by the Ad Hoc Committee of the Japan Stroke Society].
    Minematsu K
    No To Shinkei; 2006 Nov; 58(11):915-21. PubMed ID: 17133996
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
    Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
    No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
    Fonarow GC; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Grau-Sepulveda MV; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
    Circulation; 2011 Feb; 123(7):750-8. PubMed ID: 21311083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating acute ischemic stroke with intravenous alteplase.
    Vance DL
    Crit Care Nurse; 2001 Aug; 21(4):25-7, 29-32; quiz 33-4. PubMed ID: 11858686
    [No Abstract]   [Full Text] [Related]  

  • 9. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous thrombolysis with rt-PA in acute stroke patients aged >or=80 years.
    Toni D; Lorenzano S
    Int J Stroke; 2009 Feb; 4(1):21-2. PubMed ID: 19236493
    [No Abstract]   [Full Text] [Related]  

  • 11. IV t-PA therapy in acute stroke patients with atrial fibrillation.
    Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Yamashita S; Aoki J
    J Neurol Sci; 2009 Jan; 276(1-2):6-8. PubMed ID: 19010485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
    Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
    Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
    Sharma VK; Teoh HL; Chan BP
    J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008.
    Salam KA; Ummer K; Kumar VG; Noone ML; Laila A; Ragini J
    J Clin Neurosci; 2009 Oct; 16(10):1276-8. PubMed ID: 19570685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
    J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of stroke physicians is the key to preparing IV rt-PA.
    Iguchi Y; Kimura K; Shibazaki K; Aoki J
    Cerebrovasc Dis; 2009; 28(5):460-7. PubMed ID: 19738375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
    Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
    Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status and future of recombinant tissue plasminogen activator for acute ischemic stroke].
    Sakaida H; Taki W
    No Shinkei Geka; 2009 Nov; 37(11):1067-83. PubMed ID: 19938663
    [No Abstract]   [Full Text] [Related]  

  • 20. [Can the target group for thrombolysis in acute ischemic stroke be widened? Current indication is very narrow--new study results are necessary].
    Murray V
    Lakartidningen; 2011 Jan 12-18; 108(1-2):16-7. PubMed ID: 21365808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.